321 related articles for article (PubMed ID: 23265311)
1. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research.
Guastella AJ; Hickie IB; McGuinness MM; Otis M; Woods EA; Disinger HM; Chan HK; Chen TF; Banati RB
Psychoneuroendocrinology; 2013 May; 38(5):612-25. PubMed ID: 23265311
[TBL] [Abstract][Full Text] [Related]
2. A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions.
Guastella AJ; MacLeod C
Horm Behav; 2012 Mar; 61(3):410-8. PubMed ID: 22265852
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin plasma concentrations after single intranasal oxytocin administration - a study in healthy men.
Gossen A; Hahn A; Westphal L; Prinz S; Schultz RT; Gründer G; Spreckelmeyer KN
Neuropeptides; 2012 Oct; 46(5):211-5. PubMed ID: 22884888
[TBL] [Abstract][Full Text] [Related]
4. A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.
DeMayo MM; Song YJC; Hickie IB; Guastella AJ
Paediatr Drugs; 2017 Oct; 19(5):391-410. PubMed ID: 28721467
[TBL] [Abstract][Full Text] [Related]
5. A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
Guastella AJ; Ward PB; Hickie IB; Shahrestani S; Hodge MA; Scott EM; Langdon R
Schizophr Res; 2015 Nov; 168(3):628-33. PubMed ID: 26150070
[TBL] [Abstract][Full Text] [Related]
6. No side-effects of single intranasal oxytocin administration in middle childhood.
Verhees MWFT; Houben J; Ceulemans E; Bakermans-Kranenburg MJ; van IJzendoorn MH; Bosmans G
Psychopharmacology (Berl); 2018 Aug; 235(8):2471-2477. PubMed ID: 29915962
[TBL] [Abstract][Full Text] [Related]
7. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
[TBL] [Abstract][Full Text] [Related]
8. Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model.
Quintana DS; Alvares GA; Hickie IB; Guastella AJ
Neurosci Biobehav Rev; 2015 Feb; 49():182-92. PubMed ID: 25526824
[TBL] [Abstract][Full Text] [Related]
9. Intranasal oxytocin administration engenders blocked vasopressin homeostatic responses but no salivary vasopressin increases.
Düsing R; Tops M; Quirin M
Peptides; 2015 Dec; 74():70-1. PubMed ID: 26471906
[No Abstract] [Full Text] [Related]
10. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
[TBL] [Abstract][Full Text] [Related]
11. Design of experiments to optimize an in vitro cast to predict human nasal drug deposition.
Shah SA; Dickens CJ; Ward DJ; Banaszek AA; George C; Horodnik W
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):21-9. PubMed ID: 23461532
[TBL] [Abstract][Full Text] [Related]
12. Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application.
Tanaka A; Furubayashi T; Arai M; Inoue D; Kimura S; Kiriyama A; Kusamori K; Katsumi H; Yutani R; Sakane T; Yamamoto A
Mol Pharm; 2018 Mar; 15(3):1105-1111. PubMed ID: 29338251
[TBL] [Abstract][Full Text] [Related]
13. A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis.
Cacciotti-Saija C; Langdon R; Ward PB; Hickie IB; Scott EM; Naismith SL; Moore L; Alvares GA; Redoblado Hodge MA; Guastella AJ
Schizophr Bull; 2015 Mar; 41(2):483-93. PubMed ID: 24962607
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin administration affects the production of multiple hormones.
Weisman O; Feldman R
Psychoneuroendocrinology; 2013 May; 38(5):626-7. PubMed ID: 23582729
[No Abstract] [Full Text] [Related]
15. Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder.
Alvares GA; Quintana DS; Whitehouse AJ
Autism Res; 2017 Jan; 10(1):25-41. PubMed ID: 27651096
[TBL] [Abstract][Full Text] [Related]
16. Consistency and efficacy of two methods of intranasal oxytocin application in dogs.
Schaebs FS; Deschner T; Range F; Karl S; Marshall-Pescini S
Domest Anim Endocrinol; 2020 Jul; 72():106436. PubMed ID: 32114215
[TBL] [Abstract][Full Text] [Related]
17. [The uterine contraction stress test with oxytocin nasal spray in the diagnosis of hypoxemia].
Hohmann M; Künzel W; Kirschbaum M
Z Geburtshilfe Perinatol; 1986; 190(5):210-4. PubMed ID: 3811448
[TBL] [Abstract][Full Text] [Related]
18. Cerebral and extracerebral distribution of radioactivity associated with oxytocin in rabbits after intranasal administration: Comparison of TTA-121, a newly developed oxytocin formulation, with Syntocinon.
Ishii D; Kageyama M; Umeda S
PLoS One; 2021; 16(12):e0261451. PubMed ID: 34929003
[TBL] [Abstract][Full Text] [Related]
19. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella AJ; Einfeld SL; Gray KM; Rinehart NJ; Tonge BJ; Lambert TJ; Hickie IB
Biol Psychiatry; 2010 Apr; 67(7):692-4. PubMed ID: 19897177
[TBL] [Abstract][Full Text] [Related]
20. Unitary hormonal models, peripheral markers, and evaluation of response to drug: a response to Weisman and Feldman.
Guastella AJ; Alvares GA; Hickie IB; Chan HK; Chen TF; Banati RB
Psychoneuroendocrinology; 2013 May; 38(5):627-8. PubMed ID: 23582730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
